Jul 14, 2025 07:55AM ProKidney Corp. (PROK) PT Raised to $7 at Guggenheim

Jul 9, 2025 03:33PM ProKidney Corp (PROK) call put ratio 1.2 calls to 1 put on 44K contracts

Jul 9, 2025 01:33PM BofA Securities Reiterates Underperform Rating on ProKidney Corp. (PROK)

Jul 8, 2025 04:49PM ProKidney Corp. (PROK) PT Raised to $9 at Citi

Jul 8, 2025 03:28PM BofA Securities Reiterates Underperform Rating on ProKidney Corp. (PROK)

Jul 8, 2025 07:00AM ProKidney reports positive phase 2 trial results for kidney disease therapy

Jul 1, 2025 12:44PM ProKidney Corp (PROK) Completes Domestication from the Cayman Islands to Delaware

Jun 30, 2025 06:13AM BofA Securities Downgrades ProKidney Corp. (PROK) to Underperform

May 12, 2025 05:08PM ProKidney Corp. (PROK) Tops Q1 EPS by 3c

Jan 7, 2025 05:48PM Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Nov 12, 2024 07:36AM ProKidney Corp. (PROK) Misses Q3 EPS by 1c

Sep 30, 2024 03:38AM JPMorgan Starts ProKidney Corp. (PROK) at Neutral

Sep 10, 2024 02:21AM Guggenheim Starts ProKidney Corp. (PROK) at Buy

Sep 4, 2024 05:23AM ProKidney Corp. (PROK) PT Lowered to $3 at BofA Securities

Sep 3, 2024 04:49PM BTIG Reiterates Buy Rating on ProKidney Corp. (PROK)

Sep 3, 2024 07:31AM ProKidney Corp (PROK) Announces Strategic Updates to its Phase 3 Program

Aug 13, 2024 04:59AM ProKidney Corp. (PROK) PT Lowered to $5 at BTIG

Jun 12, 2024 05:48AM ProKidney Corp (PROK) Prices Upsized 53.72M Share Offering at $2.42/sh

Jun 11, 2024 05:25AM BofA Securities Reiterates Neutral Rating on ProKidney Corp. (PROK)

Jun 10, 2024 04:15PM ProKidney Corp (PROK) Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024 12:53PM ProKidney Corp. (PROK) PT Lowered to $6 at Jefferies

Jun 10, 2024 05:30AM ProKidney Corp (PROK) Announces Positive Interim REGEN-007 Phase 2 Trial Data, Provides Clinical and Operational Updates